Skip to content
Bored Studies
RecruitingAccepts healthy volunteers

Triple Negative Breast Cancer and Germline Hereditary Breast and Ovarian Cancer Mutation Carrier Registry

University of Kansas Medical Center · NCT02302742

View Study & Apply (opens in a new tab)

Opens the official ClinicalTrials.gov record, with the study team’s contacts. Bored Studies doesn’t enroll anyone.

Key facts

Compensation
Not posted. Ask the study team before screening.
Who can join
Any age listed · All sexes
Healthy volunteers
Accepted
Study type
Observational
Target enrollment
3000
US sites recruiting
11
Study start
March 22, 2011
Record last updated
August 18, 2026

Status re-checked against ClinicalTrials.gov within the last 12 hours.

What the study is about

PROGECT is a registry for patients with Triple Negative breast cancer (TNBC) or patients who have an identified germline mutations (such as a mutation on the BRCA1 or BRCA2 genes).

Conditions: Breast Cancer; Hereditary Breast and Ovarian Cancer

Eligibility criteria

Copied from the official record. The study team makes the final decision at screening.

Show full criteria

Inclusion criteria include

Triple Negative Breast Cancer

  • ER/PR \<10% and HER negative per current ASCO/CAP guidelines
  • Stages I-IV
  • Any age at diagnosis
  • Patient must be within 5 years of diagnosis
  • Eligible regardless of genetic testing status
  • Genetic testing recommended for patients meeting NCCN and Medicare guidelines

AND/OR

Germline mutation Carriers

  • Patients with deleterious or uncertain mutations in HBOC genes (BRCA, PTEN, P53, -PALB2 etc) are eligible regardless of type/site of cancer
  • Healthy patients harboring mutations also eligible
  • There is no time limit from the time of diagnosis of cancer and enrollment.
  • Eligible regardless of personal history of cancer

Exclusion Criteria include

Triple Negative Breast Cancer -Patient is not within five years of diagnosis

Germline mutation Carriers

-Patient only carries a HBOC mutation that is classified as "polymorphism" of "favor polymorphism"

Recruiting US locations

  • Hays Medical Center Dreiling-Schmidt Cancer Institute

    Hays, KS 67601

    Site contact: Josette Klaus · 785-623-5761

  • KCCC West

    Kansas City, KS 66112

    Site contact: Kristina Sharpe-Pringle · 913-328-3206

  • KCCC Overland Park

    Overland Park, KS 66210

    Site contact: Christy Kuechler · 9132340459

  • Overland Park Regional Medical Center

    Overland Park, KS 66215

    Site contact: Amy Nelson · 913-498-7892

  • Salina Regional Health Center - Tammy Walker Cancer Center

    Salina, KS 67401

    Site contact: Melanie Leepers, RN, MBA · 785-452-7038

  • The University of Kansas Cancer Center

    Westwood, KS 66205

    Site contact: Joshua M Staley · (913) 588-8548 · jstaley2@kumc.edu

  • Universtiy Health

    Kansas City, MO 64108

    Site contact: Nikki Malomo · 8164044093

  • KCCC South

    Kansas City, MO 64131

    Site contact: Adrienne Harris-Connell · 816-823-6640

  • Research Medical Center

    Kansas City, MO 64132

    Site contact: Jennifer Feeback · 8162764000

  • KCCC - North

    Kansas City, MO 64154

    Site contact: Nicole Jenci · 816-584-4879

  • KCCC Lee's Summit

    Lee's Summit, MO 64064

    Site contact: Jan Ward · 816-350-5825

Study contacts (from the official record)

  • Joshua Staley · 913-588-8548 · jstaley2@kumc.edu
All healthy volunteers studies in Kansas →
Triple Negative Breast Cancer and Germline Hereditary Breast and… (NCT02302742) | Bored Studies